Efficacy of rituximab and plasmapharesis in an adult patient with antifactor H autoantibody-associated hemolytic uremic syndrome: A case report and literature review

Antifactor H antibody (anti-CFHAb) is found in 6% to 25% cases of atypical hemolytic uremic syndrome (aHUS) in children, but has been only exceptionally reported in adults. There is no consensus about the best treatment for this type of aHUS. We report the case of an adult patient treated successful...

Descripción completa

Detalles Bibliográficos
Autores principales: Deville, Clemence, Garrouste, Cyril, Coppo, Paul, Evrard, Bertrand, Lautrette, Alexandre, Heng, Anne Elisabeth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
5200
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5265956/
https://www.ncbi.nlm.nih.gov/pubmed/27684863
http://dx.doi.org/10.1097/MD.0000000000005007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5265956/
https://www.ncbi.nlm.nih.gov/pubmed/27684863
http://dx.doi.org/10.1097/MD.0000000000005007

Ejemplares similares